Prophylactic treatment of meningeal leukemia in children by intrathecal methotrexate.
D001856:Bone Marrow Examination; D001927:Brain Diseases / Q000188:drug therapy* / Q000209:etiology; D002493:Central Nervous System Diseases / Q000209:etiology; D002555:Cerebrospinal Fluid / Q000166:cytology; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007278:Injections, Spinal; D007945:Leukemia, Lymphoid / Q000150:complications / Q000188:drug therapy* / Q000532:radiotherapy; D008297:Male; D008578:Meninges; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000008:administration & dosage*; D012075:Remission, Spontaneous; D014750:Vincristine / Q000627:therapeutic use
D014750:Vincristine; D015122:Mercaptopurine; D008727:Methotrexate